Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials

Clinical Infectious Diseases

Volumn 22, Issue 2, 1996, Pages 341-347

  Wood, M J ^a   Kay, R ^b   Dworkin, R H ^b   Soong, S J ^b   Whitley, R J ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HERPES ZOSTER; HUMAN; META ANALYSIS; NEURALGIA; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

EID: 0030063252     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.2.341     Document Type: Review

References (25)

1. Wood M, ed. Management strategies in herpes: how can the burden of zoster-associated pain be reduced? Worthing, United Kingdom: PPS Europe, 1993.
2. Bhala BB, Ramamoorthy C, Bowsher D, Yelnoorker KN. Shingles and postherpetic neuralgia. Clin J Pain 1988;4:169-74.
3. Watson CPN, Watt VR, Chipman M, Birkett N, Evans RJ. The prognosis with postherpetic neuralgia. Pain 1991;46:195-9.
4. Watson CPN. Postherpetic neuralgia. Neurol Clin 1989;7:231-48.
5. Robinson PN, Fletcher N. Postherpetic neuralgia. Journal of the Royal College of General Practitioners 1986;36:24-8.
6. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain [letter]. Lancet 1994;343:1648.
7. Huff JC, Bean B, Balfour HH Jr, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988;85(suppl 2A):84-9.
8. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989;102:93-5.
9. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85(suppl 2A):79-83.
10. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991;10(suppl):177-82.
11. Freestone DS, Brigden WD. Acyclovir and post-herpetic neuralgia [letter]. Lancet 1990;335:1279.
12. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis 1991;(suppl 80):62-8.
13. Huff JC, Drucker JL, Clemmer A, et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol 1993;(suppl 1): 93-6.
14. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900.
15. Riopelle JM, Naraghi M, Grush KP. Chronic neuralgia incidence following local anaesthetic therapy for herpes zoster. Arch Dermatol 1984;120:747-50.
16. Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 1992;101:200-5.
17. de Moragas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Dermatol 1957;75:193-6.
18. Hope-Simpson RE. Postherpetic neuralgia. Journal of the Royal College of General Practitioners 1975;25:571-5.
19. SAS/STAT software. Cary, North Carolina: SAS Institute.
20. Kalbfleisch JD, Prentice RL. The analysis of failure-time data. New York: Wiley, 1978.
21. Pocock S. Meta-analysis [editorial]. Stat Methods Med Res 1993;2: 117-9.
22. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
23. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-53.
24. Fiddian AP, International Zoster Study Group. A randomized controlled trial of acyclovir versus netivudine for the treatment of herpes zoster. Antiviral Res 1995;26:A297.
25. Degreef H, Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. International Journal of Antimicrobial Agents 1994;4:241-6.